Popular diabetes drugs not linked to thyroid cancer risk, study finds

Drugs known as GLP-1 analogs have become increasingly popular to treat diabetes and obesity, but there have been concerns that they might increase the risk of thyroid cancer.

Related Keywords

Norway ,Sweden ,Solna ,Stockholm ,Denmark ,Swedish ,Peter Ueda ,Karolinska Institutet ,Department Of Medicine ,Swedish Cancer Society ,Swedish Research Council ,Cancer ,Diabetes ,Drugs ,Thyroid ,Thyroid Cancer ,Agonist ,Flood ,Blood Sugar ,Glp 1 ,Glucagon ,Medicine ,Obesity ,Eceptor ,Research ,Type 2 Diabetes ,